Strontium89 (strontium chloride Sr-89 injection, USP) / Q BioMed - LARVOL DELTA

"#QBioMed Bolsters Commercialization of #Strontium89 with #EVERSANA Partnership $QBIO https://t.co/UElS2wltaF" (@1stOncology)

Licensing / partnership

Q BioMed Expands Strontium89 Reach Through Agreement with UroGPO, the Largest Group Purchasing Organization for Independent Urology Clinics in the US (PRNewswire) - "Q BioMed...announced today that it has been awarded a contract with UroGPO, the largest Group Purchasing Organization for urology private practice clinics in the US...Through the partnership, UroGPO will support the establishment of Strontium89 (Strontium Chloride Sr-89 Injection, USP) as an added radionuclide therapeutic choice...Strontium89 will be offered to UroGPO urology offices that treat patients with painful bone metastases from prostate and other urological cancers."

Licensing / partnership • CNS Disorders • Genito-urinary Cancer • Oncology • Pain • Prostate Cancer

Strontium89 Now Reimbursed in Hospital and Outpatient Settings for Metastatic Bone Pain Treatment (PRNewswire) - "Q BioMed...announced today that the Centers for Medicare and Medicaid Services (CMS) updated the Outpatient Prospective Payment System (OPPS) reimbursement rate for its FDA approved non-opioid metastatic bone pain drug Strontium89 (Strontium Chloride Sr-89 Injection, USP) on January 3, 2021."

Reimbursement • Musculoskeletal Pain • Pain